Overview
Legal name
BASTION THERAPEUTICS LIMITED
Region
Unknown
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Bastion Therapeutics Limited
Error
Bastion Therapeutics Limited is a UK company with status active founded in 2018.
CRN
11597069
Founded
2018
Age
7
Company events
Reference milestones and recent Companies House filing stream events.
4 events
19 Nov
2024
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ0NDEzODMwMmFkaXF6a2N4
Published 19 Nov 2024 05:02
12 Nov
2024
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQ0Mjc4NDQzMGFkaXF6a2N4
Published 12 Nov 2024 10:02
10 Oct
2024
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQzOTA3NjQwMmFkaXF6a2N4
Published 10 Oct 2024 04:45
01 Oct
2018
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2020
Funded years
2020
Age at first award
1 years
Projects
2020
Feasibility Studies
Lead participant
In-house cell therapy production during COVID19 pandemic
1 Jun 2020 to 31 Mar 2021
Awarded
£56,919
Total cost £56,919
no public description
2020
Study
Lead participant
'Degen-lock' - a novel way of protecting the nervous system in Motor Neurone Disease
1 Apr 2020 to 30 Sep 2021
Awarded
£324,829
Total cost £464,042
We are developing a treatment for a neurological disease called motor neuron disease (MND). There is no cure for MND and the current therapies on the market do little to delay disease progression. This condition is caused by the death of a particular subset of brain cells known as motor neurons. These cells normally instruct muscles when to move, and thei...
Product types
Feasibility Studies
Study